[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Glaser, 1980 - Google Patents

Indomethacin‐sensitive suppressor cells regulate the cell‐mediated cytotoxic response to SV 40‐induced tumor‐associated antigens in mice

Glaser, 1980

Document ID
14559927572061503548
Author
Glaser M
Publication year
Publication venue
European Journal of Immunology

External Links

Snippet

Specific secondary cytotoxic reactivity (as measured by 51Cr‐release assay) against SV 40‐ induced tumor‐associated antigens was generated in vitro in spleen cells of tumor‐free (BALB/c× C57 BL/6) F1 (CBF1) mice immunized against a syngeneic SV 40‐induced tumor …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Similar Documents

Publication Publication Date Title
Paige et al. Natural cytotoxic cells against solid tumors in mice: II. Some characteristics of the effector cells
Miossec et al. Production of interleukin 1 by human endothelial cells.
Walsh et al. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1.
Trinchieri et al. Antibody-dependent cell-mediated cytotoxicity in humans: I. Characterization of the effector cell
Unanue et al. Persistence of antigen on the surface of macrophages
Lee et al. Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia.
Callewaert et al. Cytotoxicity of human peripheral lymphocytes in cell-mediated lympholysis; antibody-dependent cell-mediated lympholysis and natural cytotoxicity assays after mixed lymphocyte culture
Cole et al. Interactions of mycoplasmas and their products with lymphoid cells in vitro
Hawrylowicz et al. Regulation of antigen-presentation-I. IFN-gamma induces antigen-presenting properties on B cells.
Austyn et al. Clustering with dendritic cells precedes and is essential for T-cell proliferation in a mitogenesis model.
James et al. Immunoregulatory function of T cells activated in the autologous mixed lymphocyte reaction.
Glaser Indomethacin‐sensitive suppressor cells regulate the cell‐mediated cytotoxic response to SV 40‐induced tumor‐associated antigens in mice
Morimoto et al. Studies of Anti‐lymphocyte Antibody of Patients with Active SLE: I. Cause of Loss of Suppressor T‐Lymphocyte Function
Tomasi Jr Serum factors which suppress the immune response
JP3147916B2 (en) In vitro immunization method
Claasen et al. A cell culture system that enhances mononuclear cell IgE synthesis induced by recombinant human interleukin-4
Hanna et al. Normal immunosuppressive protein: inhibitory effect on immune response against tumour cells.
Brondz et al. Enrichment of effector T lymphocytes specific to H‐2 antigens by elution from allogeneic target cells and characterization of the eluted lymphocyte population
Doria et al. In vitro primary immune response resulting from the interaction between bone marrow-derived and thymus cells
Toge et al. Induction of suppressor cell activities in normal lymphocytes by sera from gastric cancer patients.
Touraine Human T-lymphocyte differentiation in immunodeficiency diseases and after reconstitution by bone marrow or fetal thymus transplantation
Igarashi et al. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
Kubo et al. Direct cytotoxicity against chicken erythrocytes in mice. I. Fundamental nature of T cell-mediated cytotoxicity.
Takahashi et al. Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patients
Yamasaki et al. Immunoregulatory effects of interleukin 2 and interferon on syngeneic murine malignant glioma-specific cytotoxic T-lymphocytes